Aging Clinical and Experimental Research

, Volume 5, Issue 6, pp 445–449 | Cite as

Plasma fibrinogen and physiological aging

  • Patrick Laharrague
  • J. P. Cambus
  • G. Fillola
  • J. X. Corberand
Original Article


Results of prospective studies indicate that increased fibrinogen concentration is significantly associated with the risk of arteriosclerotic vessel disease. As the fibrinogen concentration is considered to rise with aging, determination of its physiological values with various methods in strictly healthy adult and aged individuals is a prerequisite to evaluating the relative contribution of fibrinogen to cardiovascular diseases. Fibrinogen concentration was determined in 209 healthy subjects, aged 19 to 96 years. Persons over the age of 60 were recruited according to the stringent criteria of the Senieur protocol established for human immunogerontological studies. Fibrinogen concentrations, obtained by heating precipitation and by thrombin clotting time with both electromagnetic water-bath and semiautomatic coagulometer, ranged from 1.55 to 3.70 g/L. A rise in plasma concentration was observed with aging. Independently of age, females exhibited higher concentrations than males. Significantly higher values were observed in subjects over 60 years of age, in both sexes, in comparison with the younger groups. (Aging Clin. Exp. Res. 5: 445–449, 1993)


Aging arteriosclerosis coagulation fibrinogen 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Meade T.W., North W.R.S., Chakrabarti R.R., Stirling Y., Haines A.P., Thompson S.G.: Haemostatic function and cardiovascular death: early results of a prospective study. Lancet I: 1050–1054, 1980.CrossRefGoogle Scholar
  2. 2.
    Meade T.W., Mellows S., Brozovic M., Miller S.G., Chakrabarti R.R., North W.R.S., Haines A.P., Stirling Y., Imeson J.D., Thompson S.G.: Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park heart study. Lancet II: 533–537, 1986.CrossRefGoogle Scholar
  3. 3.
    Baker I.A., Eastham R., Elwood P.C., Etherington M., O’Brien J.R., Sweetnam P.M.: Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br. Heart J. 14: 490–494, 1982.CrossRefGoogle Scholar
  4. 4.
    O’Connor N.T.J., Cederholm-Williams S., Copper S., Cotter L.: Hypercoagulability and coronary artery disease. Br. Heart J. 52: 614–616, 1984.PubMedCrossRefGoogle Scholar
  5. 5.
    Wilhelmsen L., Svardsudd K., Korsan-Bengsten K., Larsson B., Welin L., Tibblin G.: Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311: 501–505, 1984.PubMedCrossRefGoogle Scholar
  6. 6.
    Stone M.C., Thorpe J.M.: Plasma fibrinogen — a major coronary risk factor. J. R. Coll. Gen. Pract. 35: 565–569, 1985.PubMedGoogle Scholar
  7. 7.
    Kannel W.B., D’Agostino R.B., Belanger A.J.: Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study. Am. Heart J. 113: 1006–1010, 1987.PubMedCrossRefGoogle Scholar
  8. 8.
    Exner T., Burridge J., Power P., Rickard K.A.: An evaluation of currently available methods for plasma fibrinogen. Am. J. Clin. Pathol. 71: 521–527, 1979.PubMedGoogle Scholar
  9. 9.
    Jespersen J., Sidelman J.: A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen. Acta Haematol. 67: 2–7, 1982.PubMedCrossRefGoogle Scholar
  10. 10.
    Palareti G., Maccaferri M., Manotti C., Tripodi A., Chantarangkul V., Rodeghiero F., Ruggeri M., Mannucci P.M.: Fibrinogen assays: a collaborative study of six different methods. Clin. Chem. 37: 714–719, 1991.PubMedGoogle Scholar
  11. 11.
    Oswald M.W., Hunt H.H., Lazarchick J.: Normal range of plasma fibrinogen. Am. J. Med. Technol. 49: 57–59, 1983.PubMedGoogle Scholar
  12. 12.
    Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Muller-Hemerlink H.K., Steinmann G.G.: Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 28: 47–55, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Corberand J., Laharrague P., Fillola G.: Blood cell parameters do not change during physiological human ageing. Gerontology 33: 72–76, 1987.PubMedCrossRefGoogle Scholar
  14. 14.
    Foster J.B.T., De Natale A., Dotti L.B.: Determination of plasma fibrinogen by means of centrifugation after heating. Am. J. Clin. Pathol. 31: 42–45, 1959.PubMedGoogle Scholar
  15. 15.
    Clauss A.: Gerinnungsphysiologische schnell Methode zur Bestimmung des Fibrinogens. Acta Haematol. 17: 237–247, 1957.PubMedCrossRefGoogle Scholar
  16. 16.
    Furlan M., Felix R., Escher N., Lämmle B.: How high is the true fibrinogen content of fibrinogen standards? Thromb. Res. 56: 583–592, 1989.Google Scholar
  17. 17.
    Miale J.B.: Hemostasis and blood coagulation. In: Miale J.B. (Ed.), Laboratory Medicine Hematology. C.V. Mosby Company, St. Louis, 1967, pp. 999–1115.Google Scholar
  18. 18.
    Nilsson I.M.: Mechanism of normal haemostasis. In: Nilsson I.M. (Ed.), Haemorrhagic and Thrombotic Diseases. John Wiley & Sons, London, 1971, pp. 1–50.Google Scholar
  19. 19.
    Balleisen L., Bailey J., Epping P.H., Schulte H., van de Loo J.: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb. Haemost. 54: 475–479, 1985.Google Scholar
  20. 20.
    Stout R.W., Crawford V.: Seasonal variations in fibrinogen concentrations among elderly people. Lancet 338: 9–12, 1991.PubMedCrossRefGoogle Scholar

Copyright information

© Editrice Kurtis s.r.l. 1993

Authors and Affiliations

  • Patrick Laharrague
    • 1
  • J. P. Cambus
    • 1
  • G. Fillola
    • 1
  • J. X. Corberand
    • 1
  1. 1.Service d’HématologieCHU Toulouse-RangueilToulouse CédexFrance

Personalised recommendations